BPC-157: Everything You Need to Know—Benefits, Risks, & Safety

#BPC157 #PeptideTherapy #TendonHealing #RegenerativeMedicine #healthscience BPC-157 is everywhere right now — but does the evidence actually justify putting this peptide into your body? In this video, Dr. Mohammed Paika (board-certified internal medicine & obesity medicine) breaks down what BPC-157 actually does, what the animal research shows, what we really know about human safety, and the one theoretical risk that concerns him most as a physician.BPC-157 is not FDA-approved for any human use.🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter📚 The Weight Equation & The Physician’s Physiquehttps://www.drmohammedpaika.com/books👥 Metabolic Health Communityhttps://www.skool.com/metabolic-health-community-5316Timestamps0:00 – Intro: Does the evidence justify this?0:44 – What BPC-157 Actually Is2:19 – How BPC-157 Works (The Mechanism)4:18 – The Musculoskeletal Evidence7:51 – Gut Health10:58 – Brain & Nervous System13:14 – Cardiovascular Health14:07 – The Honest Safety Picture16:20 – What Human Data We Actually Have19:24 – The Risk That Concerns Me Most (Cancer)21:46 – Who Should Actually Consider This24:26 – The Regulatory Reality (FDA, 2026)ReferencesStaresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon. J Orthop Res. 2003;21(6):976-983.Krivic A, et al. Achilles detachment in rat and BPC 157: tendon-to-bone healing. J Orthop Res. 2006;24(5):982-989.Cerovecki T, et al. Pentadecapeptide BPC 157 improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-1161.Staresinic M, et al. Effective therapy of transected quadriceps muscle in rat: BPC 157. J Orthop Res. 2006;24(5):1109-1117.Novinscak T, et al. BPC 157 as effective therapy for muscle crush injury in the rat. Surg Today. 2008;38(8):716-725.Šebečić B, et al. Osteogenic effect of BPC-157 on segmental bone defect healing in rabbits. Bone. 1999;24(3):195-202.Duzel A, et al. BPC 157 in colitis and ischemia/reperfusion in rats. World J Gastroenterol. 2017;23(48):8465-8488.Vuksic T, et al. BPC 157 heals ileoileal anastomosis in the rat. Surg Today. 2007;37(9):768-777.Sikiric P, et al. BPC 157 effects on stomach mucosa integrity and blood pressure. Life Sci. 1994;54(5):PL63-68.Park JM, et al. BPC 157 rescued NSAID-cytotoxicity via intestinal permeability. Curr Pharm Des. 2020;26(25):2971-2981.Tudor M, et al. Traumatic brain injury in mice and BPC 157 effect. Regul Pept. 2010;160(1-3):26-32.Vukojević J, et al. BPC 157 in hippocampal ischemia/reperfusion injuries in rats. Brain Behav. 2020;10(8):e01726.Gjurasin M, et al. Peptide therapy with BPC 157 in traumatic nerve injury. Regul Pept. 2010;160(1-3):33-41.Perovic D, et al. BPC 157 improves healing course of spinal cord injury in rats. J Orthop Surg Res. 2019;14:199.Zemba Cilic A, et al. BPC 157 counteracts catalepsy in rat schizophrenia-like models. Behav Brain Res. 2021;396:112919.Sikiric P, et al. Antidepressant effect of BPC 157 in Porsolt's test and chronic stress in rats. J Physiol Paris. 2000;94(2):99-104.Xu C, et al. Preclinical safety evaluation of BPC-157. Regul Toxicol Pharmacol. 2020;114:104665.He W, et al. Pharmacokinetics of BPC-157 in rats and dogs. Front Pharmacol. 2022;13:1026182.Lee E, et al. Effect of BPC-157 on interstitial cystitis symptoms: a pilot study. Altern Ther Health Med. 2024;30:12-17.Lee E, Burgess C. Safety of IV infusion of BPC-157 in humans: a pilot study. Altern Ther Health Med. 2025.Lee E, Padgett B, et al. Intra-articular BPC 157 for knee pain. Altern Ther Health Med. 2021;27(S1).ClinicalTrials.gov. Study of BPC-157 in healthy volunteers. NCT02637284. Withdrawn.Nair AB, Jacob S. Dose conversion between animals and humans. J Basic Clin Pharm. 2016;7(2):27-31.U.S. FDA. Pharmacy Compounding Advisory Committee vote on BPC-157, July 23, 2026. See also: Pharmaceutical Executive, July 24, 2026.U.S. FDA. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks.⚕️ MEDICAL & EDUCATIONAL DISCLAIMER: This content is for general educational and informational purposes only and is not medical advice or a substitute for care from your healthcare provider. Viewing this content does not create a doctor-patient relationship. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, diet, exercise, or weight-loss plan. Individual results and risks vary. You assume responsibility for decisions made based on this content.